Fred B. Craves

Board Director

Director

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€1.7M

Latest filing published 14 Mar 2025 for Madrigal Pharmaceuticals, INC., €103k. Read the official filing

Filing timeline

BuySale

Fred B. Craves

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Fred B. Craves: trading record in brief

This profile gathers the share dealings of Fred B. Craves in Madrigal Pharmaceuticals, Inc., where the filings describe the role as board member. Over a trading history stretching from 3 December 2021 to 12 March 2025, the count stands at 10 filings.

No open-market purchase appears, only 2 sales worth €1.7M. Outside the open market, there are 2 share grants and 2 option exercises.

The newest entry dates from 14 March 2025: an option exercise of €103k, in Madrigal Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.